Tournament: UK Season Opener | Round: 2 | Opponent: Little Rock Central XJ | Judge: Michael Fain
Value - Morality
Criterion - Util
Contention 1 - COVID 19
The COVID-19 emergency is a global crisis which will only continue to fester and proliferate until immediate and perhaps global action is taken. Uncertainties and variants with potentially more infectious tendencies are on the rise until innovation is aided with the reduction of Intellectual property protections.
World Health Organization. (n.d.). 2021WHO director-general's opening remarks at the WTO - WHO high Level DIALOGUE: Expanding Covid-19 Vaccine manufacture to Promote equitable access. World Health Organization. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-wto~-~--who-high-level-dialogue-expanding-covid-19-vaccine-manufacture-to-promote-equitable-access.
Without doubt, the development
AND
Rapid diagnostics and life- saving therapeutics are also vital.
Suspension of intellectual property rights
Time to suspend intellectual property protections ON COVID-19... Transparency.org. (2021, May 7). https://www.transparency.org/en/press/time-to-suspend-intellectual-property-protections-on-covid-19-vaccines.
Pharmaceutical companies had
AND
companies producing vaccines have signed up.
Contention 2 is Ebola
Subpoint A- The occurrence of public health emergencies of global concern such as Ebola has served to highlight further the tensions between IPP and access to medicines.
Motari, M., Nikiema, J.-B., Kasilo, O. M. J., Kniazkov, S., Loua, A., Sougou, A., and Tumusiime, P. (2021, March 11). The role of intellectual property rights on access to medicines in the WHO AFRICAN region: 25 years after the TRIPS agreement. BMC Public Health. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951129/.
The Ebola crisis again
AND
needed research and development.
Subpoint B- Health must come first in order to achieve general welfare
Macdonald, G. (2014, October 15). Free trade and strong ip held back ebola vaccine development says ngo. outsourcing.https://www.outsourcing-pharma.com/Article/2014/10/15/Free-trade-and-strong-IP-held-back-Ebola-vaccine-development-says-NGO.
The lack of an Ebola
AND
markets that cannot pay.”
Contention 3 - Compulsory Licensing
Compulsory licensing, a provision in the TRIPS agreement, enables governments to supply its citizens with generic versions of patented treatments. Compulsory licensing was used as a successful policy tool for improving access to antiretroviral drugs in the face of the AIDS epidemic. Just as this strategy has tackled health crises in the past, it is key to tackling present illnesses that lack accessible treatments.
Wong, H. (2020). The Case for Compulsory Licensing During Covid-19, 1–5. https://doi.org/ 10.7189/jogh.10.010358
The Doha Declaration reaffirmed that
AND
measures in the time of a pandemic.